Craniotomy Completed Phase 3 Trials for Sevoflurane (DB01236)

IndicationStatusPhase
DBCOND0021273 (Craniotomy)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00741351Anesthesiological Strategies in Elective CraniotomyTreatment